13 completed, 4 unknown, 2 not yet recruiting. 19 Phase 2, 4 Phase 3, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 19 | Completed 13, Unknown 4, Not yet recruiting 2 |
| Phase 3 | 4 | Completed 3, Not yet recruiting 1 |
| Phase 1 | 2 | Completed 1, Unknown 1 |
Follow Trematode Infections: new trials by email Literature Review of Trematode Infections trials Research Report on Trematode Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Different Treatment Frequencies for Hepatic Fibrosis Due to Schistosomiasis Praziquantel 40 mg/kg per dose given once annually, Praziquantel 40 mg/kg given three times per year - Schistosomiasis, Schistosoma Mansoni | Phase 2 / Phase 3 | Not yet recruiting | Rhode Island Hospital | 600 | 2026-11-01 | 2026-08-12 |
| One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis Oxfendazole, Triclabendazole - Fascioliasis | Phase 2 | Not yet recruiting | Universidad Peruana Cayetano Heredia | 336 | 2026-08-15 | 2026-06-03 |
| Sm-p80 Schistosomiasis Challenge Study Sm-p80 + GLA-SE Vaccine, Placebo, Schistosoma mansoni infection - Schistosoma Mansoni, Schistosomiasis | Phase 2 | Unknown | Leiden University Medical Center | 48 | 2024-09-01 | 2023-10-17 |
| Anti-Schistosomiasis Sm14-vaccine in Senegal Sm14 recombinant vaccine+ GLA-SE adjuvant - Schistosomiasis Mansoni, Schistosomiasis Haematobium | Phase 2 | Unknown | Oswaldo Cruz Foundation | 120 | 2022-07-01 | 2022-12-21 |
| Clinical Evaluation of Ujiplus® Against Schistosoma Mansoni Ujiplus®, Praziquantel 400mg - Schistosoma Mansoni | Phase 2 / Phase 3 | Completed | Kenya Medical Research Institute | 400 | 2021-05-06 | 2022-07-12 |
| Praziquantel in Children Under Age 4 Praziquantel - Schistosomiasis, Schistosomiasis Mansoni | Phase 2 | Completed | Rhode Island Hospital | 354 | 2021-02-01 | 2026-04-23 |
| Selexipag for the Treatment of Schistosomiasis-Associated Pulmonary Arterial Hypertension Selexipag - Pulmonary Hypertension, Schistosomiasis | Phase 2 | Unknown | University of Sao Paulo General Hospital | 20 | 2020-10-15 | 2020-10-19 |
| Sm-TSP-2 Schistosomiasis Vaccine in Healthy Ugandan Adults Sm-TSP-2/Alhydrogel® vaccine, Sm-TSP-2/Alhydrogel® vaccine plus AP 10-701, ENGERIX-B Hepatitis B Vaccine - Schistosomiasis, Schistosoma Mansoni | Phase 1 / Phase 2 | Completed | Baylor College of Medicine | 290 | 2019-10-07 | 2025-11-04 |
| Treatment of Female Genital Schistosomiasis (FGS) With Praziquantel: A Proof-of-Concept Study Praziquantel 600Mg Oral Tablet x 5, Praziquantel 600Mg Oral Tablet x 1 - Schistosomiasis | Phase 2 / Phase 3 | Completed | Regionshospital Nordjylland | 116 | 2019-09-03 | 2020-05-18 |
| Anti-Schistosomiasis Vaccine: Sm14 Phase 2b-Sn in School Children Sm14, GLA-SE solution - Schistosomiasis | Phase 2 | Completed | Oswaldo Cruz Foundation | 95 | 2018-12-13 | 2019-12-09 |
| Effect of Artemisinin-based Combination Therapies on Schistosomiasis on Malaria Co-infection Artesunate-Pyronaridine, Artemether-Lumefantrine, Artefenomel-Ferroquine - Schistosomiasis Haematobia | Phase 2 | Completed | Centre de Recherche Médicale de Lambaréné | 54 | 2018-07-31 | 2020-02-11 |
| Study of Safety and Immune Response of the Sm14 Vaccine in Adults of Endemic Regions Sm14, GLA-SE solution - Schistosomiasis | Phase 2 | Completed | Oswaldo Cruz Foundation | 30 | 2016-12-06 | 2017-12-14 |
| An Open Label Dose Finding Safety and Efficacy in Children and Infants Infected With Schistosomiasis (S.Mansoni) Biltricide (racemate praziquantel) oral tablets, Racemate Praziquantel ODT, Levo Praziquantel ODT - Schistosomiasis | Phase 2 | Completed | Merck KGaA, Darmstadt, Germany | 444 | 2016-06-12 | 2019-11-20 |
| Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis parasitological diagnostics (coproscopy), Nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet - Ulcerative Colitis, Ulcerative Colitis Exacerbation | Phase 1 / Phase 2 | Unknown | Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan | 300 | 2015-01-01 | 2023-03-03 |
| Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents MVA85A - Tuberculosis | Phase 2 | Completed | University of Oxford | 36 | 2014-06-01 | 2015-01-30 |
| Schistosoma Mansoni Morbidity in Children Aged 1-5 Years Praziquantel - Intestinal Schistosomiasis | Phase 2 | Completed | Makerere University | 800 | 2012-12-01 | 2014-09-17 |
| Activity of Mefloquine Against Urinary Schistosomiasis Mefloquine, S/P - Urinary Schistosomiasis | Phase 2 | Completed | Albert Schweitzer Hospital | 65 | 2010-05-01 | 2013-01-24 |
| S. Japonicum and Pregnancy Outcomes Praziquantel, Placebo - Schistosomiasis | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 370 | 2007-08-01 | 2016-01-26 |
| Comparing Praziquantel Versus Artesunate + Sulfamethoxypyrazine/Pyrimethamine for Treating Schistosomiasis Artesunate+Sulfamethoxypyrazine/pyrimethamin, Praziquantel - Schistosoma Haematobium | Phase 2 / Phase 3 | Completed | Dafra Pharma | 800 | 2007-08-01 | 2008-01-18 |
Schistosomiasis (13) · Schistosomiasis haematobia (4) · Schistosomiasis mansoni (3) · Schistosomiasis japonica (2) · Colitis, Ulcerative (1) · Fascioliasis (1) · Hypertension, Portal (1) · Hypertension, Pulmonary (1) · Infections (1) · Liver Cirrhosis (1) · Protozoan Infections (1) · Pulmonary Arterial Hypertension (1) · Tuberculosis (1)
Helminthiasis (19) · Parasitic Diseases (19) · Infections (18) · Vector Borne Diseases (17) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Male Urogenital Diseases (4) · Schistosomiasis (4) · Urinary Tract Infections (4) · Urogenital Diseases (4) · Urologic Diseases (4) · Digestive System Diseases (3) · Liver Diseases (2) · Actinomycetales Infections (1)
Praziquantel (8) · SM14 protein, Schistosoma mansoni (2) · glucopyranosyl lipid-A (2) · Artemether, Lumefantrine Drug Combination (1) · MVA 85A (1) · Mefloquine (1) · Mesalamine (1) · Tablets (1) · Triclabendazole (1) · nitazoxanide (1) · oxfendazole (1) · pyronaridine tetraphosphate, artesunate drug combination (1) · selexipag (1)
Oswaldo Cruz Foundation (3) · Rhode Island Hospital (2) · Albert Schweitzer Hospital (1) · Baylor College of Medicine (1) · Centre de Recherche Médicale de Lambaréné (1) · Dafra Pharma (1) · Kenya Medical Research Institute (1) · Leiden University Medical Center (1) · Makerere University (1) · Merck KGaA, Darmstadt, Germany (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Regionshospital Nordjylland (1) · Research Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan (1) · Universidad Peruana Cayetano Heredia (1) · University of Oxford (1)
Uganda (5) · Senegal (3) · Gabon (2) · Brazil (1) · Germany (1) · Kenya (1) · Madagascar (1) · Mali (1) · Philippines (1) · United Kingdom (1)
Miriam Tendler, MD, PhD (2) · Alison Elliot (1) · Allen Nalugwa, PhD (1) · Annette Olsen, PhD (1) · Bodo S Randrianasolo, MD (1) · Caio J Fernandes, PHD (1) · Edridah Muheki, PhD (1) · Elijah M Songok, PhD (1) · Fred Nuwaha, PhD (1) · Hannah Kibuuka, MD (1) · Hector H Garcia, MD PhD (1)
PMID 19150418, PMID 2022660, PMID 21298114, PMID 23284726, PMID 26571311, PMID 33998661, PMID 19802383, PMID 23175561, PMID 26511959, PMID 27441564, PMID 28472067, PMID 29546300, PMID 30469320, PMID 30687792, PMID 31188820, PMID 33188747, PMID 33861768, PMID 35788749, PMID 36315579, PMID 36342912, PMID 40412398
R01AI184979 (1), R01HD095562 (1), U01AI155323 (1)